Article Text

Download PDFPDF

#1105 The impact of final breast surgical margins distance after neoadjuvant systemic treatment and breast-conserving surgery on recurrence and survival
  1. Clémence Ortega1,
  2. Mathilde Lecomte2,
  3. Nejla Gumus1,
  4. Paulus Kristanto2,
  5. Filip De Neubourg1,
  6. Denis Larsimont2,
  7. Isabelle Veys1 and
  8. C Florin Pop2
  1. 1Institut Jules Bordet, Brussels, Belgium
  2. 2Université Libre de Bruxelles, Brussels, Belgium


Introduction/Background There is no evidence that resection margins after breast conserving surgery (BCS), defined as ’no ink on tumor’ can be applied to patients receiving neoadjuvant systemic treatment (NST). The study aim was to evaluate the impact of the distance of the resection margins on the loco-regional recurrence (LRR) and the survival of patients treated by BCS following NST.

Methodology This is a retrospective study including patients who underwent NST followed by BCS. The LRR-free survival (LRRS), disease-free survival (DFS) and overall survival (OS) was assessed according to the tumor margin distance status at final pathology. The Kaplan-Meier method was used to analyze survival and the Cox model was used to perform uni and multivariate analyzes.

Results A total of 235 patients were included in this study. Median tumor size at diagnosis was 30mm (7–75mm). A neoadjuvant chemotherapy was administrated to 91.5% patients. A complete response at imaging has been found in 27.3% of patients and 32.5% of them showed no residual tumor at final pathology. The final pathology found positive (’no ink on tumor’) margins in 8,9% patients and margins ≤1mm in 11.1% women. With a median follow-up of 63.4 months, there were 26 LRR. The 5 years LRRS was 88.7% in patients with negative margins and 87.3% in those with positive margins (p=0.7093). The surgical margins >1mm seem to be more benefic, with a LRRS at 91.5% comparing to those with margins ≤1mm (78.4%, p=0.0013). This surgical margin, >1mm, have been found to be significant for both DFS (p=0.0006) and OS (p=0.0013).

Conclusion The surgical margin distance >1mm seem to be the most appropriate surgical margin for breast cancer patients treated with BCS after NST. This margin >1mm could be useful to ameliorate the LRRS (p=0.0013), the DFS (p=0.0006) and OS (p=0.0013) of these group of breast cancer patients.

Disclosures None

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.